ICAD: icadmed.com Company Value to Net Income

iCAD - graphic logo of issuer ICAD

iCAD, Inc. (ICAD) attracts leading radiologists and ML engineers, maintaining a stable research staff despite labor shortages. The business model relies on a cloud-based SaaS service, enabling the scaling of cancer diagnostics without capital expenditures. This chart illustrates a market valuation reaching -20.70, confirming the status of the developer of patent-protected mammography analysis software that is deeply integrated into medical center infrastructure.

Price to Earnings Ratio: iCAD Corp (ICAD) for 07/04/2022 - 08/02/2025

Comprehensive metric breakdowns and analytics for iCAD Inc. (ICAD)

- share price and expert price forecast:
Price Performance Chart iCAD Corp|ICAD - Consensus Target
- market capitalization information:
Market Value iCAD, Inc.|ICAD - Enterprise Value
- balance sheet net asset value indicators:
Accounting Value per Share iCAD|ICAD - Company Net Assets|Market Capitalization to Book Value Ratio icadmed.com|ICAD - Aggregate Company Assets
- debt and solvency information:
All Debt to Shareholders' Equity Ratio iCAD, Inc.|ICAD - Long-Term Debt to Capital|Current Liabilities to Capital iCAD Corp|ICAD - Company Aggregate Debts|Debts to Net Assets iCAD, Inc.|ICAD - Company Long-Term Debts|Company Current Liabilities iCAD|Quick Ratio icadmed.com
- company profitability and valuation multiples indicators:
ICAD - Net Profit|Net Profit Forecast iCAD, Inc.|ICAD - Price to Earnings Ratio|Future Price to Earnings Multiple iCAD Corp|ICAD - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio iCAD, Inc.|ICAD - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months iCAD|ICAD - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months icadmed.com|ICAD - Net earnings per share growth this year|Consensus forecast of earnings per share growth for next year iCAD, Inc.
Summary company analysis:iCAD, Inc.
Flagship merchandise of iCAD

The P/E ratio determines the investment payback period through the ratio of market capitalization to net income. The dynamics of the P/E multiple allow for the objective tracking of the cost of each unit of income. This coefficient measures the degree of an asset's overvaluation relative to its actual ability to generate profit. For iCAD, Inc. (ICAD), this metric reflects the efficiency of combining software sales with medical equipment. The diversification of AI solutions stabilizes cash flows, smoothing the volatility of the fundamental valuation.

Key competitors

ONC: Company Value to Net Income|Price to Earnings Ratio HALO (Halozyme)|RVMD (Revolution Medicines Inc) - Company Value to Net Income|P/E Multiple AAPG (Ascentage)|CGON - Price to Earnings Ratio|URGN: Price to Earnings Ratio|BCAX - P/E Multiple|Personalis (PSNL) - Price to Earnings Ratio|Erasca Inc - Company Value to Net Income|DCTH (Delcath) - P/E Multiple|Market Cap to Earnings Y-mAbs Corp YMAB|P/E Multiple AURA|Business Payback Period candeltx.com|P/E Multiple ARAY (Accuray)|SLS - Price to Earnings Ratio|Actuate Therapeutics, Inc - P/E Multiple|CTOR - P/E Multiple|HURA: P/E Multiple|Price to Earnings Multiple TARA|Price to Earnings Ratio FATE|WHWK: Company Value to Net Income|P/E Multiple TCRX|Business Payback Period championsoncology.com|Price to Earnings Ratio XBiotech XBIT|CVM: Price to Earnings Multiple|OS Therapies - P/E Multiple|radiopharmtheranostics.com (RADX) - Price to Earnings Ratio|ARTV (artivabio.com) - Price to Earnings Ratio|ANL - Business Payback Period|VERU (Veru Inc.) - P/E Multiple|tempesttx.com (TPST) - Business Payback Period|P/E Multiple XLO|Price to Earnings Ratio renovarobio.com RENB|P/E Multiple MURA (Mural Oncology)|P/E Multiple Kairos Pharma Limited KAPA|OnKure - P/E Multiple|GDTC (CytoMed Therapeutics) - Price to Earnings Multiple|CRIS: P/E Multiple|Price to Earnings Ratio Apollomics|THAR (Tharimmune Corp) - P/E Multiple|P/E Multiple Advanced Biomed Corp|Price to Earnings Ratio Genprex, Inc. (GNPX)|calidibio.com - Price to Earnings Multiple|P/E Multiple SBFM (Sunshine Biopharma, Inc.)|XBIO - Price to Earnings Ratio|Salarius - P/E Multiple|Market Cap to Earnings Kitov Pharma|aoncology.com (AONC) - Price to Earnings Ratio|beigene.com - Company Value to Net Income|Price to Earnings Ratio CKPT|ELEV: Company Value to Net Income|P/E Multiple IKNA|Price to Earnings Ratio Notable Labs Corp NTBL|Viracta Therapeutics, Inc. - Price to Earnings Ratio|P/E Multiple morphosys.com MOR|NAYA - Price to Earnings Ratio|Company Value to Net Income AAPGV (Ascentage Pharma Group International)